| Pharmaceutical Information |
| Drug Name |
Indium in-111 pentetreotide |
| Drug ID |
BADD_D01154 |
| Description |
Indium In 111 pentetreotide (Octreoscan) has been used in trials studying the diagnostic of SARCOIDOSIS, Solid Tumors, and cushing syndrome. |
| Indications and Usage |
Not Available |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB11835
|
| KEGG ID |
D01859
|
| MeSH ID |
C081788
|
| PubChem ID |
3081912
|
| TTD Drug ID |
D0J7CP
|
| NDC Product Code |
Not Available |
| UNII |
M312JJ6Z32
|
| Synonyms |
pentetreotide | indium-pentetreotide | OctreoScan | OctreoScan 111 | indium In 111 pentetreotide | 111-indium-pentetreotide | 111 In -pentetreotide | indium ln-111 pentetreotide | In-111 pentetreotide |
|
| Chemical Information |
| Molecular Formula |
C63H84InN13O19S2 |
| CAS Registry Number |
159201-00-0 |
| SMILES |
[H+].CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32
)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)
[O-])CC(=O)[O-])C(=O)NC(CO)C(C)O)O.[In+3] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
